Literature DB >> 2928996

Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.

L Bjermer1, R Lundgren, R Hällgren.   

Abstract

The connective tissue components hyaluronan (hyaluronic acid) and type III procollagen peptide were measured in bronchoalveolar lavage fluid in 22 patients with idiopathic pulmonary fibrosis and 21 healthy control subjects. The patients with idiopathic pulmonary fibrosis had higher concentrations of hyaluronan (median 46 micrograms/l) and type III procollagen peptide (median 0.45 micrograms/l) than the healthy controls (9 and less than 0.02 micrograms/l; p less than 0.001). The patients had normal serum concentrations of hyaluronan and of the procollagen peptide, and albumin concentrations in lavage fluid similar to those of the control subjects. Neutrophil and lymphocyte counts in lavage fluid were increased on average 10 and two fold respectively in the patients with idiopathic pulmonary fibrosis and both correlated with the amount of hyaluronan recovered (p less than 0.05). An inverse correlation was seen between the transfer factor for carbon monoxide and hyaluronan concentrations in lavage fluid in the patients (p less than 0.05). Deterioration in lung function and radiographic progression were seen over six months in 12 of the patients. These patients had higher lavage fluid concentrations of hyaluronan and type III procollagen peptide than the patients whose disease was stable (p less than 0.01). Increased synthesis of hyaluronan and type III procollagen peptide in lung parenchyma may reflect activation or proliferation (or both) of pulmonary fibroblasts in idiopathic pulmonary fibrosis and seems to be linked to the severity and activity of the lung disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928996      PMCID: PMC461712          DOI: 10.1136/thx.44.2.126

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  32 in total

1.  Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.

Authors:  J E Gadek; J A Kelman; G Fells; S E Weinberger; A L Horwitz; H Y Reynolds; J D Fulmer; R G Crystal
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

2.  Biochemical characteristics and biological significance of the genetically-distinct collagens.

Authors:  E J Miller
Journal:  Mol Cell Biochem       Date:  1976-12-10       Impact factor: 3.396

3.  Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity.

Authors:  J C Sisson; C W Castor; J A Klavons
Journal:  J Lab Clin Med       Date:  1980-08

4.  Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.

Authors:  E C Lawrence; R R Martin; R M Blaese; R B Teague; R J Awe; R K Wilson; W J Deaton; K Bloom; S D Greenberg; P M Stevens
Journal:  N Engl J Med       Date:  1980-05-22       Impact factor: 91.245

5.  Determination of hyaluronate in biological samples by a specific radioassay technique.

Authors:  U B Laurent; A Tengblad
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

6.  Radioimmunoassay for type III procollagen peptide and its application to human liver disease.

Authors:  H Rohde; L Vargas; E Hahn; H Kalbfleisch; M Bruguera; R Timpl
Journal:  Eur J Clin Invest       Date:  1979-12       Impact factor: 4.686

Review 7.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects.

Authors:  R G Crystal; J D Fulmer; W C Roberts; M L Moss; B R Line; H Y Reynolds
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

8.  Interrelationship between stimulation of prostaglandin E and hyaluronate production by poly (I) . poly (C) and interferon in synovial fibroblast culture.

Authors:  M Yaron; I Yaron; C Wiletzki; U Zor
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

9.  Circulating immune complexes in the idiopathic interstitial pneumonias.

Authors:  R B Dreisin; M I Schwarz; A N Theofilopoulos; R E Stanford
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

10.  Cells, enzymes and interstitial lung disease. The Philip Ellman Lecture.

Authors:  M Turner-Warwick; P L Haslam; A Lukoszek; P Townsend; F Allan; R M Du Bois; C W Turton; J V Collins
Journal:  J R Coll Physicians Lond       Date:  1981-01
View more
  46 in total

1.  A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; R A Bundey; P C Prodanovich; P Fagan; C S Baccei; A M Santini; J H Hutchinson; T J Seiders; T A Parr; P Prasit; J F Evans; D S Lorrain
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.

Authors:  J Ye; H Wu; Y Wu; C Wang; H Zhang; X Shi; J Yang
Journal:  Eye (Lond)       Date:  2012-05-18       Impact factor: 3.775

Review 3.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

4.  CD44: one ligand, two functions.

Authors:  A Aruffo
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

5.  Innate immune signaling and stem cell renewal in idiopathic pulmonary fibrosis.

Authors:  Paul F Mercer; Rachel C Chambers
Journal:  Nat Med       Date:  2016-11-08       Impact factor: 53.440

6.  Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Authors:  Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 7.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

8.  Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates.

Authors:  Martin D Rees; Clare L Hawkins; Michael J Davies
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

9.  Hyaluronan (hyaluronic acid) in lung lavage of asbestos-exposed humans and sheep.

Authors:  A M Cantin; P Larivée; M Martel; R Bégin
Journal:  Lung       Date:  1992       Impact factor: 2.584

10.  Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.

Authors:  Fei Gao; Jeffrey R Koenitzer; Jacob M Tobolewski; Dianhua Jiang; Jiurong Liang; Paul W Noble; Tim D Oury
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.